Adial Pharmaceuticals Inc (ADIL)
0.9685 +0.0045 (+0.47%) 14:19 ET [NASDAQ]
0.9620 x 4,000 0.9947 x 1,000
Realtime by (Cboe BZX)
0.9620 x 4,000 0.9947 x 1,000
Realtime 0.9700 +0.0060 (-) 08:00 ET
for Thu, Jan 23rd, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
Operating Expenses | 2,212 | 2,287 | 1,845 | 1,784 | 1,358 |
Operating Income | -2,212 | -2,287 | -1,845 | -1,784 | -1,358 |
Other Income | 20 | -171 | -4,632 | -121 | 10 |
Pre-tax Income | -2,192 | -2,458 | -6,477 | -1,904 | -1,348 |
Net Income Continuous | -2,192 | -2,458 | -6,477 | -1,904 | -1,348 |
Net Income Discontinuous | N/A | N/A | N/A | -16 | -37 |
Net Income | $-2,192 | $-2,458 | $-6,477 | $-1,920 | $-1,385 |
EPS Basic Total Ops | -0.38 | -0.59 | -2.19 | -0.63 | -1.18 |
EPS Basic Continuous Ops | -0.38 | -0.59 | -2.19 | -0.32 | -1.14 |
EPS Basic Discontinuous Ops | N/A | N/A | N/A | -0.32 | -0.03 |
EPS Diluted Total Ops | -0.38 | -0.59 | -2.19 | -0.63 | -1.18 |
EPS Diluted Continuous Ops | -0.38 | -0.59 | -2.19 | -0.32 | -1.14 |
EPS Diluted Discontinuous Ops | N/A | N/A | N/A | -0.32 | -0.03 |
EPS Diluted Before Non-Recurring Items | N/A | -0.59 | -0.68 | N/A | -1.14 |
EBITDA(a) | $-2,211 | $-2,287 | $-1,845 | $-1,784 | $-1,358 |